YKL-40 and Complications in Type 2 Diabetes

NCT01387984 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 473

Last updated 2011-07-06

No results posted yet for this study

Summary

In this study, the investigators plan to establish the relationship between plasma concentration of YKL-40 with various vascular complications in the patients of type 2 diabetes.

Conditions

Sponsors & Collaborators

  • National Science and Technology Council, Taiwan

    collaborator OTHER_GOV
  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chih-Hung Lin, M.D. · National Taiwan University Hospital, Yun-Lin Branch

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01387984 on ClinicalTrials.gov